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Antihemophilic factor A (AHF) or blood coagulation factor VIII is defined. as the
plasma factor, which activity is deficient or absent in haemophilia A. Haemophilia A
is defined as a clinical picture of a haemorrhagic diathesis with a recessive sex-linked
inheritance, distinguishable from haemophilia B and other congenital haemorrhagic
diatheses. This definition of factorVlll leaves unanswered all questions of biochemical
and physico-chemical characterisatlon of the molecule(s) that is (are) responsible for
the factor VIII activity. On basis of this definition the defioiency of a plasmatic
coagulation factor found in most patients with von Willebrand's fisease is to be
regarded as a deficiency of factor VIII. This statement does not, however, state whether
the deficiency in haemophilia A and" von Willebrand's plasma has the same molecular
basis or not. Mutatis mutandis the same holds for the increased factor VIII-(like)
activity found after exercise or adrenaline injection; or the increased activity found in
late pregnancy.
It has been found by different authors that when plb,sma is stored, its factor VIII
activity initially decreases fast, but becomes appreciably more stable after some time(r,4, t0, r3, r9,25).
We too found (19, 20), tlnat in normal citrated plasma incubated at 37' C at pII 7.8
the factor VIII activity drops to about'50o/o of its initial value during the first 8-12 h
and that d.uring the following 4 days practically no further drop in activity is found.
This loss of factor VIII rictivity cannot be the result of a random molecular degrad.a-
tion (see also Tig.l) as would be expected to occur when a first order denaturation
reaction was the cause of the inactivation. It is the aim of this article to further explore
the reason for this phenomenon.
The inactivation of factor VIII in vitro and the experimental confitions that
influence it are of practical and theoretical importance beciuse:
1. At preparation and storage of plasma or of concentrates of factor VIII, used for
the management of haemophilic bleeding, one of the handicaps is the lability of
factor VIII. Prevention of the rapid initial inactivation of factor VIII might have
considerable advantages for the treatment of haemophilia A.
2. Following intravenous injection of normal plasma or factor VIII concentrates to
patients with haemophilia A the factor \IIII activity in the circulating blood dis-
*) This work was carried out and nearly finished under the supervision of the late Prof. van Cre-
veld. His much regretted death in march 1971 made that he could nof help us with the final
form of the publication. We have listed him as fhe senior author, as we would have done during his
lifetime, but now we do this in grateful remembrance of a pionoer in biomedical chemistry and an
inspiring teacher, Any mistake or misinterpretation of the experiments of coulse is our sole re-
sponsibiti0y. J. S., H. C. H.
**) Department of Haemosbasis and Thrombosis Research, Academic Hospital Dykzigt,
Rotterdam, The Netherlands.
***) Laboratories for Coagulation and Cardiovascular Biochemistry, University Hospital,
Leiden, The Netherlands.
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appears in a biphasic way- The initlal rap-id.phase 
is usually interpreted as being due
to equilibration betweenihe intravascular anJextravascular 
compartments while the
subsequent slower ph#";-" .iirin"t.a t. friofogi.ri 
d.egradation After observing a
biphasic disappearanc;;;";-il"itro' the qo"Jtiott 
ariies wether t'he same process
underlvins the in -'ltro'ffi"*"""" *;grtt 'i;;i;;. 
t"rt it vivo' but is masked by
;#:;ilililii"" *tn ihe exbrava scu lar compart' m e nt''
3. Analvsis of this biphasic disappearan"" "it"'" of factor 
VIII in vitro mav glve us
inlormarion on the *"T#i;; i'tqiJrii"-."t t6l. .loiti"g 
factor' Preferably postulates
on such propert'ies should fit in with *::l:ilfrJ 
on'other known modjfications of
factorVl l lact ivi tysuchase.g'occurinv-onWil lebrand,sdisease.Tort ' ]reseIeaSonS
we investigated the *;;;;"1or iu"to" vrir'i" "it-, 
and the w-ay it rvas influenced
bv temlrerature, pII, 6'-io" to"t"ntration ';;4" 
presence of other clotting factors'
Materials anil Methods
Col lect i ,onoJblood' .Bloodwascol lectedbyvenipunctureinsi l iconizedglasstubesinone-tenth
its volume of 3.zo/osodium citrate 2 tt'O' The "rrrpl"t 
*u"u immediately cen rifuged two times 
for
io J. ut 1000 g and roo;;;p:";'f":TT *i::*:ff::1,::i"S:#ffitl:lti";ill";1"'
ments. The plaietet count of this plasma 
as a rule 
,ith BaSO, to adsorb
Res'inplasma used for the experimentt. lfY 
treat'ment' of the plasma wt
factor VII, IX, X and II was preparea *itft.po*"i"50 
W";' 20-'50 mesh Fluka AG' The biood
passed directiy from-bhe vein tirough the resin "of-.'-lt"ittto 
* siliconi'ed bottie which was kept at
meltins ice. The 0"t"" **' 
""""ffia 
t-i"" at 18d;;;4; '' No calcium concentration 
measured
in this plasma 
-r !L^ --r-i,1h ^oncentration on factor VIII the I{esin'
X'or the experiments on the influence of 
the-calcium c c tration 
plasma was prepared' ut*? ii"""J sr':Pt:51"^16lli ange' 
Jn z (Fenwal T'aboratories' Mort'on
Grove, Illinois, u. s.A.). o-th""*i*" the blood *r. t;;i"d 
i; the same way' The calciumconcentra-
tion oi ttti, n"sinplasma was 0'13 mmol/l'
ToJoIIowthe'i'mact'iaat'io'txoJfactorVII.Ii 'n.ui't'rolheplasmawasincuba-ted-insiliconizedtubesor
plastic bags. fn" 't""a'"4 
"olaitlo"* 
t'"i"g citrated r:lasma' 37' C and pH 7'8'
Af regular intervars o*o 
"n*pr"* 
*.""tut 
"n 
*.JJ"TJ; - zu" c ,ri*til assaved for factor 
vIII'
usually the samples *""e stoi"d only 
for 
""*" 
;;;;;;f,-nu-,"" longer than 1 week' Generally
sampres were taken 
"' 
':#;;;;;1*;1 *t liTYffi 
'"ii" pi"'-" a'nd art'er about' 1' 3' 6' 8' 24
and 2g h. In some experi-"rti irr",.,r,tio. r.d "ar,'j'ri* *". ".1"t*t:,u 
f"-",t."-"*t davs' To exclude
;;"ril"'"::l j'":1'+Jili$#i#::*:+*mnlig,},".*,i;;;ffi ::ffffi ?:""#J:;
sample was assayect ror
ancl assayed ntt".*r"a..to-arr*"r"" n 
rr"to"viii *"ti-rity *""" seen between the 
fresh and ths
frozen samPles'
FactorVl l lwasassayed,byaonestagemet,hodaceord. ingtodenotto landeranclBlevenberg(12)
wirh some -oain""rorlv":.r#;"ffiii.zy"l pir.*a 
f"Jr,' * severe hemophilia-A patient as a
substrate. During the t*tty *ft1""g"nts were 
kept on an ice bath'
ittu t".t *,s Performed as follows:
0.1 m1 of haemoPhilia-A Plasma'
0.1 ml of test pi'"-;d;lt'l;;; ' io ""a 
1 : 100 in veronal buffer pI[ 7'42'
0.1m1 of asusp""'o'*ora"i"Jhumanplatelets(BehringW""::lti*t'lt^""UJii?1;^, for ? min
0.1 m1 giass *ool *"tit'*t"a norrnal serum 
(200-350 mg glass wool pe:
thoroughly -*"a *itt, tt e serum. The glasswooi 
**" tn"tt""J-oved' by centrifuging for 5 
min at
fi[ti*i:l*l;***"1;"'#"""""T1"1fil1T']"'1?.1 mr cacl, 0 025 M was added and tho
clotting time measured' bor VIII, using facior IX deficient plasma 
instead
Factor IX was assayed in t'he same way 
as facr
of factor VIII a"n"i".JiT"'r*?""U i*i."iX 
Ueficient serum instead of normal serum'
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oniy one process. For this reason pJagma was incubated first at 
gz' c, pH 7 '8 for 24h
after which the first pt*;;o"'hf b" terminuted and then the plasma was 
divided
into three parts. one ;;;;ilt uc gi" c and the other two parts were 
incubated
further at 45 and 50" C resp. (Fig' 3)'
0 4
Incubation time (hours) linear scale
Fig:2.TheinactivationoffactorVlllinnormalcitratodplasmaatdifferenttemperaturesanda
constant pIl of 7'8' Each curve is t'he mean of at least 3 experiments
lncubaiion time (hours) linear scale
F.ig.S.TheinactivationoffactorVlllinnormalcitratedplasma.^that}rasbeenincubatedatSToC
tot 24hafter which time trr" f*,,.* *"s incubatod further at fifferent 
temperafures and constant
pII 7.8' See text' Each curve is the mean of 3 experiments'
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Influence ol pH
The influence of pH on the stability of factor VIII in vitro has been investigated by
many authors (see discussion). We investigated the factor VIII inactivation at 3 dif-
ferent pH's (6.4,7.8, S.5) (Fig.a). The pII was altered by the ad.dition of HCl0.5 N or
NaOH 0.5 N.
o  4  8  12 .  t 6  20  24  28  32  36  40
Incubat ion t ime (hours)  l inear scale
X'ig.4. The inactivation of factor VIII activity at 37' C and different pH. Each curve is the mean of
3 experiments.
At, lower pH the inactivation of factor VIII in the first phase was obviously slower
and the level o{ the second phase maintained at a higher factor VIII activity. Lower-
ing the pH does influence the dissociation of Ca-citrate, so that more Ca++ ions are
prisent.^As will be seen later, Ca++ influences the inactivation of factor VIII so that
the influence of pH changes in citrate plasma may be partly accounted for by changes
in Ca++ concentration.
Influence ol Other Coagulation Factors
It may be possible that during collection of the blood or during incubation of the
plasma one or more clotting factors or an intermediate'product has some influence on
the inactivation of factor VIIL The most simple way to investigate this is to observe
the inactivation of factor VIII in the absence of one or more other coagulation factors.
If citrated plasma contains a hypothetical substance which influences the inactiva-
tion of factor VIII and rrhich is independent of factor VIII, it may be supposed to be
present in haemopbilic A plasma.
Inlestigation of the inactivation of factor VIIIin a mixture (1 : 1) of :
a) fresh haemophilic A plasma and old normal plasma (24h,37" C, pH 7.8) and
b) old haemophilic A plasrna (24 h, 37o C, pII 7.8) and fresh normal plasma
is shown in Fig.5. The haemophilic A plasma does not seem to have any influence.
*
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Fig.5. Inactivation of factor vlll in mixtures (1:1) of haemophilic-A and normal plasma' For' 
*xplanation see text' Each curve is the mean of 3oxperiments'
n'or the invesiigation of a possible influence of factor xII, IX and v the plasma was
"-;J;fi;;i";- 
ffth ; seveie (xrr, rx) or moderate deficiency (v,3-5o/o of normal)
ii ln"u"^fu"tors. The infloence of contaci activation was also investigated by inculat-
*g 
""r*-f 
plasma i" 
"""-*ifil"*zed 
glass- In all cases the course of factor VIII in-
uc'tivation w1u,s indistinguishable from that in normal plasma (Fig.6).
The in-fluenc" of tn""tu.lo". II, V11, IX and X ias investigated in resinplasma
treated. with BaSO* ,o u, to remove tlese factors to obtain levels of less than 2o/o'
Factor vIII activity *r* not influenced by treatment with Bason' The pH of 
-the
;;;;lr-;;was T.s. fn" Uu"ti-rution of the factor VIII in the resinplasma.and--in
;h;iil; treated *iin n1sO, was the same as in normal citrated plasma (Fig'7)'
Blood, Plotelets
The citrated. plasma used for the inactivation studies of factor vIII contains
SO,O6O-1ZO,OOO ifut"f"irf**t. lfn" fact-or VIII level in this plasma is 100o/o 
by de-
finition. Platelets have absorbed some factor vIII onto their surface (3, 24)' when
platelets were remov"* isoo-zoo0 platelets/11!!3) factor vfII activity rMas found
f" f"liy" 
"i ""t*rf. 
Inactivation-of factor VIII in platelet-poor plasma was the
same as in platelet-rich plasma (Fig'7)'
Iibri,nogen
As no patients with afibrinogenaemia were available, the influence of factor I could
oot il" t irr"*tigated. ffigh fib"i;rogen levels (700-900 mC%) did not seem to influence
the inactivation of factor VIII.
rH Fresh hoemophi l ic-A plosmo * o ld normol  p losmo
l--  -  t  Old hoemophi l ic-A plosmo + f resh normol  Plosmo
49:;
^r.-..--r Foct. Xll deficient plosmo
r- ---r normol plosmo, nonsiliconized incubotion
2 0 2 4 2 8 3 2 % 4 0 4 4 4 8
Incubation t ime (hours) l inear scale
H Foct. V deficient plosm
A- --A Foct.lX deficient plomo
o  4  I  1 2  1 6  2 0 2 4 2 8 3 2  3 5 4 0  4 4 4 8 5 2
lncubation time (hours) l inear scale
X'ig.6. Inactivation of factor VIfI in plasmas deficient in factor XIf, IX, or V and in normaf
. 
plaqma incubated in non-siliconized glass tubes. Each curve is the mean of 3 oxperiments.
Thrombin
Trace amounts of thrombin are known to activate factor VIII (15, 16). Iligher con-
ceutrations of thrombin destroy factor VIII (22). As the same rate of factor \IIII in-
activation was found in plasma deficient in the factors Xff, IX; or Y, as well as in
BaSOn adsorbed. plasma and in platelet-poor plasma as in normal plagma, a role of
thrombin becomes very improbable under the conditions in our experiments. Accord-
ing to Rtzza and Walker (17) heparin (0.075 u/ml) can prevent the inactivation of
factor VIII by thrombin (0.15 u/mt). The addition of heparin to normal platelet-poor
citrated plasma (final concentration 0.075 u/ml), did not change the inactivation curve
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Incubation t ime (hours) l inear scale
X'ig.8. Inact'ivation of factor VIIf in platelet poor citrated plasma (PPP 500-1000 platelets/mm3)
with heparine 0.075 u/ml, normal citrated plasma with hirudine 1 y/ml and normal citrated plasma
rvith EACA 0.1M. Each curve is the mean of 2 experiments.
Fibri,nolytic System
Addition of EACA (final concentration 0.1 M) to normal plasma did not alter the
inactivation curve of factor VTTI (Eig.8). pH was not influenced by this concentraLion
Of EACA.
Influence ol C11+;'
That Ca++ improves the stability of factor VIII has been assumed for a long time(28) and was proven by Weiss in 1965 (26). The experiments of Weiss made it unlikely
that another bivalent cation is o{ influence on the stability of factor VIII.
- 
To investigate the role of Ca++ resinblood u/as obtained by Tenwal tsloodpack Ion
Exchange systems (type JB-2). The calcium concentration of the plasma prepared
from this resinblood was 0.13 mM, so the quickly exchanging part of the piotein
bound calcium was also removed. The pH of the Resin plasma was 2.6-7.8.
The plasma was divided into 3 parts. one part was*used as such, to the other two
parts CaCl, (50mM solution) was added so as to obtain final concentrations of Ca++ of
0.38 mM and 0.63 mM. X'ig.9 shows the results (mean of 2 experiments).
Two facts can be observed:
ft is obvious that
a) increase of calcium concentration slo.ws down the rate of inactivation of fac-
tor VIII in the first phase;
b) the level of the second phase of the curve seems to be independent of the calcium
concentration.
53
It seems (see n'igs.2 and 3) that the inactivation rate from the rapid phase as well
as from the slow phase is temperature-dependent, although not as much as is describ-
ed for irreversible protein denaturation processes.
The level of the slow phase differs with temperature too, it is lower as the tempera-
ture increases (compare F, in Table 1).
Table 1. The influenco of the temperature on the initial disappearance rate (Vt) of factor VIII
Temp , 'C
o
2 L
/ x
CU
1.nt
1.80
1.82
40
F r
J D
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b 5
The curves are analysed as the sum of two exponentials, which fairly well accounts
for the observations. V, is the initial velocity due to the first exponential. n" is the
fraction of the total activity broken down with that velocity.
The experiments with different calcium concentration (Fig.9) do not make it likely
that rve have to do with a reaction of the type
VIII - Ca++ <= VIIIi f Qa++
(YIII1 : inactive factor VIII)
as in this case it would be expected that the level of the second phase, which represents
the equilibrium, were dependent on the Ca++ concentration. It may be more probable
that the Ca++ influences the time at which an equilibrium is achieved between two
active forms of factor VIII or between an active and an inactive form of factor VIII.
If this is the case it may be possible to reactivate the factor VIII in plasma which has
been incubated at low Ca++ concentration by raising the calcium concentration. I{
factor VIII activity is caused by two independant substances * although this does not,
seem to be very probable in view of the results of the experiments with different tem-
perature (see later) - it may be assumed. that the substance with the highest inactiva-
tion rate is inactivated very rapidly at low calcium concent'rations, while the second
substance, which activity is reflected by the second phase of the curve, is not affected
by the calcium concentration. fnterpreting the above mentioned experiments of the
influence of Ca++ on the inactivation of factor VIII it must be taken into account that
the influence of the pH on the inactivation rate of factor VIII in citrated plasma can be
mediated by two mechanisms:
1. the effect of H+ (resp. OH-) on the molecules with factor VIII activity;
2. effeet of pH on the dissociation of calcium-citrate and via this way on the Ca++
concentration.
The inactivation of factor VIII in citrated plasma at temperatures bet'ween 9o C and
45" C and at pI[ between 6.4 and 8.5 can be described as biphasic. fn the first 24hthe
factor VIII activity decreases to a certain value - depending on the experimental con-
ditions - after which the activity is fairly stable. It cannot be described as a simple
exnonential decrease of the factor VIII activitv which means that the inactivation
cannot be mediated by a reaction of the tgre.
z
0 . D
1 0
b D
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o5t
(A. A'etc. stands for active factor VIII molecules; I, I'etc. stands for inactive fac-
tor VIII molecules).
Hypotheses to explain the biphasic curve can be:
a;" fhe presence df a substance that inactivates factor VIII in the first phase, or the
generation of a substance that stabilizes factor VIII activity
b) The existence of two independent substances with faptor VIII activity with
different inactivation rates.
c) Reversible denaturation of factor VIII in one or more steps' ,
di Factor VIII exists in plasma in two interdependent molecular forms, one being
more active than the other.
Ad, a.
The experiments with plasma totally deficient in factor XII and TX excluded the
influence 
^of 
these factors. The influence of factor VII, X, II, V and plat'elets was not
very probable, but could not be excluded altogether as the experimerits were done in
nlasma that contained small amounts of these factors'
It could be excluded that inactivating substances (thrombin, intermediate pro-
ducts) were generated during the managing of the blood and plasma'
The transLnt existence, however, of an inactivating substance in the first phase -or
generation of a stabilizing factor in the second phase of the curve - independent of the
itottittg system - 
"utoof 
b" excluded. This substance then should also be preqent t1
hu"11o[hi]i"-A plasma : the hypothetical inactivating subst-ance in fresh haemophilic A
plas-a', the hylothetical stablHzing factor in old haemophilic A plasma. The experi-
ments with mixtures of normal uod. hu"*ophilic A plasma gave no evidence for the
existence of such a substance. This with fair probability rules out the existence of such
substances.'
A d  b .
The existence of two ind.ependent substances with factor VIII activity-witl_dltre-
rent inactivation rates is woith considering. The rapid phase of the curve should then
represent the inactivation of both substances. The second phase, on the other hand'
"eiresents 
the inactivation of the most stable substance only. The activity of the
latter at zero time can be found. by extrapolating the line'that represents the second
phase of the curve towarcls zero-time (i. e. its intercept with the Y- axis). At different
irr ana at different temperatures this activity at zero time mult then be identical.'Th" 
irnpr"*.ion, howevei, is (see Figs.4 ancl 2) that this is not the case. This makes
hypothesis b less likely.
Act, c.
protein denaturation can be defined as the loss of one or more specific properties_of
the native protein. We can say then that we studied the denaturation of factor VIII,
by the decline of its specific function in blood coagulatio-n.
Protein denaturation can be described as a series of changes in the protein molecule
(8,  21) .
Somewhere in this process
This mav be represented as
the specific biological activity of the protein gets lost.
A  + A ' + I  + T '  - r I "
Reversible protein d.enaturation has been described. In fact we have seen condi-
tions that gave an increase of factor vTTI activity during incubation (20).
oo
To explain than the biphasic inactivation of'factor VIII in vitro there are several
possibilities which are simplifications of this denaturation scheme.
The most simple one is
A  * l
As has been said., reactivation of factor VIII cannot be excluded. so we have to
write
A  = I
To explain the slow decrease of the second phase it must be assumed that I is irre-
versibly changed to I', the reaction I + I' being slower than A + I. The denatura-
tion of factor VIII can be represented then as
A + I * I '
If such an equilibrium does exist, we have to assume that it exists in vitro as well
as in vivo because the half-life times in vivo and in vitro are of a comparable order
of magnitude. Then the question arises why the equilibrium is changed. when blood is
taken from the donor. The only obvious difference is the change in Ca++ concentra-
tion. As shown,before, the Ca++ concentration does influence the velocity with which
the equilibriumis reached, but not the position of the equilibrium. The change in Ca++
concentration cannot be the sole explanation therefore of the change in the equilibrium.
One has to realize, however, that in vivo factor VIII is in d;mamic equilibrium with
sy'nthesis and biological turnover. This may be represented as:
synthesis  -+A +I  +I '
biological turnover.
When the rate of synthesis of factorVlll is of the same order of magnitude as bio-
logical turnover the reaction A + I will not be in chemical equilibrium in vivo, but
there will be an excess of A. In vitro the reaction will approach chemical equilibrium,
which we observe as the rapid phase of the disappearance curve of factor VIII activity.
If we take into account that there is some evidence that two molecular forms of
factorVlll exist (23,27) denahrration according tot the following scheme is an alter-
native possibility
rn vivo this wourd give 
A + A' + r
sSrnthesis -+ A <= A'
++
+ I
+,
biological turnover.
If we assume that A is more active than A' and that in vivo there is an excess of A
the biphasic decrease of factor VIII activity in vitro can be explained also in this way.
Ad (t.
If two molecular forms of factor VIII exist in plasma they need not to be two steps
in a protein denaturation process. As long as these two forms are interconvertible the
same reasoning as sub c is valid. They need not be in equilibrium in plasma in vivo
because s;'nthesis and breakdown in vivo can maintain a non-equilibrium steady-state.
When blood is taken from the donor an equilibrium may be reached between these
two molecular forms. If we assume that one form is more active than the other and
that reaching the equilibrium means a decrease of the most active form the biphasic
decrease of factor VIII activity in vitro can be explained.
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In conclusion the possibfities ad a and b are unlikely; at present we cannot dif-
ferentiate experimenlaly between c and d,. In fact d is a more general form of the
mechanism discussed sub c.
SummarY
when normal citrated plasma is stored a|37" c and pH !.f the factor vIII aotivity
dr;F;; about so"/" ot itJinltiat value during the first-8-12 h. In the following + 9glt
practicallv no further d"op in activity is foind. If the logarithm of the factor vIII
;;;t"tt#pbrt"a ugui".t ti*" u."oto6 is obtained which can be described as biphasic'
f" 
""pi"r"ine 
urrdeilyitrg mechanism of this phenomenon the influence of temperature,
pH. iu** concentratiorr"arrd" some other cl6tting factors was_investigaled, B9tw99n
i"--"i"rt"t* i{zt" C un,t 4b' C the inactivation of factor Vrrr was biphasic, the
;;t"";;;;iir.i"wnr being faster in both phases at higher t-empeiat'res' The inacti-
vation at these t"*p"*t*"i showed a qro 6f abotrt 2' * UZ'^9 nearly all factor VIII
activitv disappeared. within 8 h. Possibty lle precipitation of fibrinogen at this lempe-
;;;;;;"tr;#il;;. B"tw"en plr 6.4 anil si thddecrease in factor vrrr in the first
;h;;;*"* obviously *to*"t at l6wer pH and the level of the-second phase maintained
;t; hdt;r factor VIII activity. No ilteration of the normal inactivation p,attern was
u""r, in"ptu.-a from patients #th congeni-t-aldeficiencies of factors XII, IX or V or in
normal plasma adsorbeJ with BaSOnivhich bas factors II, VII, IX and )C marked'ly
;;;;Jd, ;;"*u* tn"t" any differen6e between platelet rich and platelet poor plasma'
Lorr calcium concentrations (Resinplasma) mafuedly iricreased the rate of inactiva-
tion in the first phase, but did not influence the second phase': 
n"; hypoth'eses are given to explain t\e bip\asii inactivation of factor VIII:
,)-Ti;p;;;"ce of an inaEdvating suflstance in the fiIst phase or a stabilizing factor in
;il;":;J phase of factor Vlliinactivation. b) The eristence of two ind'ependent
,ob*turr"", i,ith fu,.to" \IIII activity with different inactivation rates. c) Reversible
denaturation of factor VIII in one or more steps. d) n'actor vIII exists in plaslain
i*o lrrt"ra"pendent molecular forms. It is discrissed. that in view of the results of the
;;;"d*;;Jhypotheses a and b are not very likely. At present we cannot differentiate
experimentallY between c and d.
R6sum6
Quand. le plasma citratd normal est conserv6 t 37' c et au pII 7.8 l'activit'6 
du fac-
teui1fff toirbe environ 4,50o/o de sa valeur initiale pendant les premidres 8 d' 12 heures'
pendant les 4 jours suivunts itl'y u plus d"9 chute d.;activit6. Si le logarthgg de I'acti
oitO ao facteur VIII est port6 enionition d.u temps on obtielt une courbe biphasique'
il;r 6h;id;r le m6canisire de ce ph6nomdne on i6tudi6l'influence de la temp6rature,
du pI[, de la concentration de i,** 
"t 
de q-uelques ?"t"t":,ryT5s 
de coagulation'
nndr" i"* temp6ratures de 21 et 45' C I'inaciivation du lacteur \llII est biphasique,
fu airoir"tion'd,activii6 est plus rapide dans les deux phases au_x temp6ra-tq*-Pl*
6lev6es. L,inactivation A, ces-temp6iatures a un co6fficient Qro d-'environ 2. A 52'C
;;;;;;; tooi" i'u,ctioiie du facterir VIII disparait en 8 heures. Il estlossible que la
;ilidr;'"" a" nU"i""gene )r, cette temp6rature joue un.certain r6le. Entre les pg,de
6:ffi;;^dl;;"4"; du facteur vrfr dans la premidre phase est nettement plus
lente au pH inf6rieur et le seuil de la seconde ph?-",.P3Ti93u 1 u"e 
activit6 du Tac-
ll,," VIIf pl"s 6lev6e. Il n'y a pas d.e modificatijn de I'inhibition dans le plasma de ma-
haes dendient* 
"n 
fu"i"o""* Xit, tX ou V, dans le plasma 
"glq?l 
adsorb6 par RaSOn
avec une faible activit6 r6diduelle des facteurs II, VlI, IX et I. Il n'y a pas non plus de
airJt"""" 
""tre 
les plasmas riches ou pauwes en plaquettes. Les basses concentrations
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du calcium (plasma pr6lev6 sur r6sine) acc6ldrent la premidre phase d'inactivation
mais n'influencent pas la seconde.
On donne 4 hypothdses susceptibles d'expliquer I'inactivation biphasique du fac-
teur VIII: a) la pr6sence d'une substance inactivante dans la premidre phase ou d'un
facteur stabfisant dans la sebonde. b) I'existence de deux substances ind6pendantes
avec une activit6 facteur VIII et des vitesses d.'inactivation diff6rentes. c) une inac-
tivation r6versible du facteur VIII en un ou plusieurs stades, d) le facteur VIII existe
dans le plasma sous deux formes mol6culaires interd6pend.antes. Les r6sultats indi-
quent que les hypothdses a et b ne sont pas trds probables. Actuellement il n'est pas
possible de diff6rencier exp6rimentalement entre c et d.
Zusammenlassung
Wenn norntales Zitratplasma bei 37 Grad und pH 7,8 gelagert wird, fii,llt die Fak-
tor-Vlll-Aktivitrit auf ungefd,hr 50f/o des Ausgangswertes wii,hrend der ersten 8 bis
12 Stunden. In den folgenden 4Tagenist praktisch kein weiterer Abfall der Aktivittit
zu finden. Wenn der Logarhithmus der X'aktor-Vlll-Aktivitd,t gegen dteZett' gezeich-
net wird, so erhd,lt man eine Kurve, die als zweiphasisch beschrieben werden kann.
Um den zugrundeliegenden Mechanismus dieses Phdnomens zu erforschen, wurden
der EinfluB der Temperatur, des pII, der Kalziumionenkonzentration und einiger
anderer Gerirurungsfaktoren untersucht. Zwischen 2l und 45 Grad ist die Inaktivie-
rung von n'aktor VIII biphasisch, wobei die Abnahme der Taktor-Vlll-Aktivitait in
beiclen Phasen bei hoherer Temperatur schneller ist. Die Inaktivierung zeigt bei
fiesen Temperaturen ein Qro von ungefd,hr 2. Bei 52 Grad verschwand nahezu die
gesamte Taktor-Vlfl-Aktivitii,t innerhalb von 8 Stunden. Moglicherweise ist die
X'rillung des Fibrinogens bei fieser Temperatur hierfrir von Bedeutung. Zwischen
pH 6,4 und 8,5 war die Abnahme der Faktor-Vlll-Aktivitri,t in der ersten Phase bei
niederem pH langsamer und der Spiegel der zweiten Phase blieb auf einem hoheren
Aktivitd,tsfuveau. Es wurd.e keine Anderung der normalen Inaktivierung im Plasma
von Patienten nit angeborenem Mangel an X'aktor XII, IX oder V oder im barium-
sulfatadsorbierten Normalplasma mit stark verminderten X'aktoren II, VII, IX und X
gefunden. Auch bestand kein Unterschied zw"ischen pldttchenreichem und pltittchen-
armem Plasma. Niedrige Kalziumkonzentrationen (Resinplasma) steigerten die fn-
aktivierungsgeschwindigkeit der ersten Phase betrti,chtlich, hatten aber.keinen EinfluB
auf die zweite Phase.
Es werd.en 4 Ilypothesen fiir die Erkltirung der biphasischen Inaktivierung von
Faktor VIII d.iskutiert.
a) Die Gegenwart einer inaktivierenden Substanz in der ersten Phase oder eines
stabfisierenden Taktors in der zweiten Phase der X'aktor-Vlfl-Inaktivierung.
b) Das Vorhandensein von zwei unabhdngigen Substanzen mit Faktor-Ylll'
Aktivitiit mit verschiedener Inaktivierungsgeschwindigkeit.
c) Reversible Denaturierung von X'aktor VIII in ein6m oder mehreren Schritten.
d) X'aktor VIII existiert im Plasma in zwei voneinander abhii,ngigen molekularen
Formen. Es wird diskutiert, da8 in Anbetracht der Ergebnisse der Experimente die
Hypothesen a und b nicht sehr wahrscheinlich sind.. Gegenwiirtig kann experimentell
zwischen den Hypothesen c und d nicht unterschieden werden.
Aclcnowl,eilgem'ent
Part of this work has been carried out under the a,uspices of the Netherlands Founda,tion for
Chemical Rosearch (S.O.N.) and with financial aid from the Nethorlands Organization for the
Advancemont of Puro Research (Z'W. O.).
D|J
References
(l) Barrow, E. M., J. B. Graham: Yon Willebrand's Disease. Progr. Ilemat' 4: 203 (196\.
(2) Btombcick, l}lt..: Purification of anti-hemophilic globulin. Archiv. Kemi'. 72:387 (1958).
\3) Bownameaur,J,:Dosagedesfacteursdecoagulationcontinusdansl'atmosphdreplasmatique
des plaquettes humaines. Rev. {rang. Etud' clin. bioI.2:32 (L957).
(4) Bowie, E. J. W., J. H. Thomytson, Ch. A. Ouen: Tlrc stability of anti-hemophilic globulin and
labile factor in human blood. Mayo Clin. Proc. 39: 145 (1964).
(E\ Ettis, B. C., A. Stranskg: A quick and a,ccurate method for the determination of fibrinogen in
plasma. J. Lab. clin. Med. 58; 477 (196I).
(6)  Fo,nt t ,P. ,A.G.Marr :T!rcpreservat ionof  coagulat ionfactors inhumanplasma.Aust .J.exp.
Biol .  med. Sci .  34. '433 (1956).
(7) Veissley,R.,H.Litili,n: Actionof cocain onbloodplatelets. Ilelv. physiol. pharmacol. Acta' 7:
69  (1e49 ) .
(8) Jol,y, M...A physico-chemical approach to the denaturation of proteins. Academic Press,
London and New York 1965.
(9) Kekiiiclt, R. A., P. L. Walton: Studies on the purification and stability of human anti-haemo-
philic factor (factorVIII). Brit. J. Ilaemat. 11: 537 (t965).
(10) KettenborS, H. K., S. L d,e Vries, E. T. oan der Pol.'Modification in the behaviour of coagula-
tion faciors during storage of blood and its importance for blood transfusion. Rev. belge Path.
24: 136 (1955).
(!1) Ma,mmen, E. E.: Investigations on the nature of haemophilia-A. Thrombos. Diathes. hae-
rnorr .  (Stut tg.)  9;30 (1963).
(t2) clen Ottolancler, G. J . H., A. Bleyenberg: Le dosage du facteur VIII. H6mostase 7; 281 (1961).
(13) Penick, G. D., K. M. Bri,nkhous.' Relative stability of plasma Antihemophilic factor (AHF)
under different conditions of storage. Amer. J. med.. Sci. 2 32 : 434 (t956) -
(L4) Quick, A. J.:Ha,ertorrhagic disoases. Philadelphia, Pa 1957.
(I5) Rapaport, S. J ., L Schi,fiman, M. J , Patch, S. B . Ames: The importance of activation of anti-
hemophilic giobulin and pro-a,ccelerin by traces of thrombin in the generation of intrinsic
prothrombinase activity. Blood' 21: 22t (1963).
(!6) Rapaport, /S. ,I , iS, SchifJman, S. B. Ames: Activation of antihemophilic globulin.by traces of
thrombin: 1\1essential step in intrinsic prothrombinase generation. In: K. M. Brinkhous,The
haemophilias. p.49. Chapel Hill, U. S. A. 1964.
(17) Ri,zza, c. R., w. walkcr: rnactivation of AIIG by thrombin. Nature (Lond.) 180: 143 (t957).
(18) Shi,notnanz,G. Y.: I{inetic studies on the thermai denaturation of lluman anti-haemophilic
globulin (AI{G). Thrombos. Diathes. haemorrh. (Stuttg.) 15; 636 (1966).
(Lg) Sti,bbe, J... Experiments on the spontaneous inactivation of blood clotting factor VIII in vitro.
Short Comrnunication. Fourth meeting X'EBS, Oslo 1967'
(20) Sti'bbe, J..' De inactivatie van factor VIII in vitro. Thesis, Amsterdam 1967.
(2!) Straub, 7, 8,.. Formation of the secondary and tertiary structure of enzymes. Advanc.
Enzyrnol. 26 : 89 (t964),
(22) Surgenor, D. M., Herwg W'il,son: Factor V from human plasma. Thrombos. Diathes. haemorrh'
5 ; 1  ( 1 9 6 0 ) .
(23) Thelin, G. M., R. H. Wagner: Sedimentation of plasma antihemophilic factor. Arch. Bioch.
95:70 (1s61).
(24) Waaler, B. A.: A simple one-stage method for the assay of anti-haemophilic-A factor. Scand'
J. clin. Lab. Invest. 11:194(1959\.
(28) Wagner, R. H., G. M. Theli,n: Ilaemophilia and Haemophiloid Diseases. International Sym-
posium, New York, p.3. Ed. Brinkhous, K. M. IJtiversity of North carolina Press, chapel
Hi i l ,  NC, 1957.
(26) Wei,ss, H. J.: A. study of the cation-and pH dependent stability of factors V and VIII in
plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 14:32 (L965).
(27) Wei,ss,H.J.,J.Koohu;a:Molecularformsofantihemophilicglobuiininplasma,cryoprecipitate
and after thrombin activation. Brit. J. Ilaemat. 18: 89 (1970).
(25\ WotJ, P.; Studies of temperature and pH stability of human AHF in plasma a,nd concentrate.
Brit,. J. Ilaemat. 5: 169 (1959).
Received for publication June 24,1971
Copyrisht bv F. K. Sdrattauer Verlag, Stutrgart - Der Verlag beh?ilt sidr alle Rechte, besonders die des Nadrdru&es,
dei Ver-vielf *lti gon g und der Ubersetz-un g vori
